CUV clinuvel pharmaceuticals limited

REPORT JUST DROPPED - Check this out!, page-22

  1. 1,125 Posts.
    lightbulb Created with Sketch. 1673

    Very interesting to keep tracking Clinuvel's closest comparison stock in Disc (both are primarily concerned with EPP right now). Disc are valued at a whopping $2.7 Billion AUD compared to Clinuvel just $0.5 Billion. Which is amazing when you see that highly profitable Clinuvel is a far, far superior company in nearly every way IMO. Disc burning about $1 Million every 2 days as they just keep chewing up their cash reserves in the hope of bringing their lead drug for EPP to market without completing a phase 3 trial and on the back of a phase 2 that failed on time in sunlight compared to placebo?? The Disc chief medical officer just sold another bunch of shares which has been happening quite a bit this year at Disc. Raymond James just started coverage of Disc and whacked a massive PT on them, I wonder if they have ever heard of Clinuvel now they have someone based in the States for this sort of thing? Probably could talk about stuff like Vitiligo impacting 1 or 2 percent of the planet, distribution network of 120 US centres, about $800 Million AUD for years 1-2 shown regularly to the ASX, stuff that Disc could only dream about. As usual another interesting paradox surrounding Clinuvel, all important shorting data below.

    No change to open shorts for latest day ASIC data available. Important to keep tracking this data as we can all see how lightly traded Clinuvel is and there are nearly 3 Million open shorts to be bought back by real shares and there are only 50 Million CUV shares out there. The introduction of 3 Million shorts has been destructive for the valuation, share price, and sentiment surrounding Clinuvel, even as they continue growing profits and a massive cash pile year after year. Also with the blockbuster potential of Vitiligo not far off due to the phase 3 which is running towards finality with 210 patients recruited in a trial which is showing very positive signs from a drug which is already FDA approved.

    50 thousand fake liquidity CUV short sells in the last one month alone.
    270 thousand fake shares since 10th March 25 on the back of amazing half year financial results
    1.5 Million fake Sell shares since Sept 2023 after exceptional financial full year results
    About 3 Million fake sell shares total according to ASIC data
    Extreme manipulation in a lightly traded company, usually closing shareprice near daily lows each day with a price 1 to 2% below VWAP

    Easy to strike on shareholder behalf by deploying a 1.5 Million share buyback which is nearly untouched more than one year after much fanfare and strong verbal and written words from Clinuvel.

    All IMO DYOR


    Last edited by Silverchair: Thursday, 12:29
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$9.83
Change
-0.350(3.44%)
Mkt cap ! $492.7M
Open High Low Value Volume
$10.18 $10.18 $9.75 $1.391M 140.2K

Buyers (Bids)

No. Vol. Price($)
1 9965 $9.83
 

Sellers (Offers)

Price($) Vol. No.
$9.89 370 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.